Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy.
Ma WX, Li CY, Tao R, Wang XP, Yan LJ.
Oxid Med Cell Longev. 2020 May 29;2020:5136957. doi: 10.1155/2020/5136957. eCollection 2020.
PMID:32566086
Stress-Induced Cardiomyopathy-Considerations for Diagnosis and Management during the COVID-19 Pandemic.
Moady G, Atar S.
Medicina (Kaunas). 2022 Jan 27;58(2):192. doi: 10.3390/medicina58020192.
PMID:35208516
NR4A3 prevents diabetes induced atrial cardiomyopathy by maintaining mitochondrial energy metabolism and reducing oxidative stress.
Peng H, Yuan J, Wang Z, Mo B, Wang Y, Wang Y, Wang Q.
EBioMedicine. 2024 Aug;106:105268. doi: 10.1016/j.ebiom.2024.105268. Epub 2024 Aug 3.
PMID:39098108
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
Wallace KB, Sardão VA, Oliveira PJ.
Circ Res. 2020 Mar 27;126(7):926-941. doi: 10.1161/CIRCRESAHA.119.314681. Epub 2020 Mar 26.
PMID:32213135
KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
Kyriazis ID, Hoffman M, Gaignebet L, Lucchese AM, Markopoulou E, Palioura D, Wang C, Bannister TD, Christofidou-Solomidou M, Oka SI, Sadoshima J, Koch WJ, Goldberg IJ, Yang VW, Bialkowska AB, Kararigas G, Drosatos K.
Circ Res. 2021 Feb 5;128(3):335-357. doi: 10.1161/CIRCRESAHA.120.316738. Epub 2020 Dec 2.